Why it was included in the FDA ban Research has not yet proven MOTS-C to deliver the above benefits
Pre-treatment with silymarin reduces brain myeloperoxidase activity and inflammatory cytokines in 6-OHDA hemi-parkinsonian rats
Together, they help convert destructive molecules, including free radicals, into harmless compounds
Glow Blend GHK-Cu is the most-studied compound for skin biology research, and the blend provides all three mechanisms (gene expression, angiogenesis, cell migration) at established research proportions
Tissue repair and pain research A 2025 review tracked BPC-157 from tissue regeneration toward pain modulation, collecting reports where the peptide reduced inflammatory signalling and supported nerve and tissue recovery after injury, while stressing that robust human mechanism data are not yet available [5]
Another possible explanation is differences in pain processing between males and females